EV
Evelo Biosciences, Inc.
EVLO · OTC
$0.00 +0.00% (+$0.00)
1M -99.00%
Market Cap $1.90K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
-
N/A P/FCF N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 177.72%
Asset turnover 0.00x
ROIC 201.37%
Debt
71 /100
Low Int. coverage -23.31x
Net debt/EBITDA -0.03x
Current ratio 4.16x
Stability
54 /100
Moderate EPS volatility 21.29%
Profitable years 0
Beta 1.31x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre EVLO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Craig R. Jalbert
Employees
66
Headquarters
Cambridge
Evenimente viitoare
17 NOV.
Earnings
Upcoming earnings report